Modulation of quinolinic acid-induced depletion of striatal NADPH diaphorase and enkephalinergic neurons by inhibition of nitric oxide synthase

Brain Research

Volumn 817, Issue 1-2, 1999, Pages 151-162

  Kalisch, Bettina E ^a   Jhamandas, Khem ^a   Beninger, Richard J ^a   Boegman, Roland J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Enkephalinergic; Neurotoxicity; Nitric oxide; Quinolinic acid

Indexed keywords

7 NITROINDAZOLE; CYTOCHROME B5 REDUCTASE; ENKEPHALIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUNTINGTON CHOREA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; ENKEPHALINS; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; NADPH DEHYDROGENASE; NEURONS; NEUROTOXINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033616460     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01254-2     Document Type: Article

References (64)

1. Aronin N., DiFiglia M., Graveland G.A., Schwarcz R., Wu J.-Y. Localization of immunoreactive enkephalins in GABA- synthesizing neurons of the rat neostriatum. Brain Res. 300:1984;376-380.
2. Augood S.J., McGowan E.M., Emson P.C. Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience. 59:1994;7-12.
3. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
4. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
5. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., Martin J.B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse. 3:1989;38-47.
6. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
7. Boegman R.J., Parent A. Differential sensitivity of NPY somatostatin and NADPH diaphorase containing neurons in rat cortex and striatum to quinolinic acid. Brain Res. 445:1988;358-362.
8. Boegman R.J., Smith Y., Parent A. Quinolinic acid does not spare striatal NPY-immunoreactive neurons. Brain Res. 415:1987;178-182.
9. 3H ]-gamma-aminobutyric acid: combination of Golgi-staining, autoradiography and electron microscopy J. Comp. Neurol. 213:1983;121-134.
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248.
11. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87:1990;682-685.
12. Buisson A., Margaill I., Callebert J., Plotkine M., Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61:1993;690-696.
13. Buisson A., Plotkine M., Boulu R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol. 106:1992;766-767.
14. Connop B.P., Boegman R.J., Jhamandas K., Beninger R.J. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res. 676:1995;124-132.
15. Connop B.P., Rolfe N.G., Boegman R.J., Jhamandas K., Beninger R.J. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439-1445.
16. Davies S.W., Roberts P.J. Sparing of cholinergic neurones following quinolinic acid lesions of the rat striatum. Neuroscience. 26:1988;387-393.
17. Davies S.W., Roberts P.J. No evidence for preservation of somatostatin-containing neurones after intrastriatal injections of quinolinic acid. Nature. 237:1987;326-329.
18. Dawbarn D., DeQuidt M.E., Emson P.C. Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease. Brain Res. 340:1985;251-260.
19. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide synthase mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6368-6371.
20. Fangi L., Oliver M., Lafon-cazal M., Bokaert J. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol. Pharmacol. 47:1995;1239-1247.
21. Fallon J.H., Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 249:1986;293-336.
22. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., Richardson E.P. Morphological characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46:1987;12-27.
23. Fradsen A., Schousboe A. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3(3-hydroxy-5-methoxyisoxazole)propionate and kainate in cultured cerebral cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2590-2594.
24. Fukuto J.M., Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase. Ann. Rev. Pharmacol. Toxicol. 35:1995;165-194.
25. Garthwaite G., Garthwaite J. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices. Neuropharmacology. 33:1994;1431-1438.
26. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurol. Sci. 14:1991;61-67.
27. Globus M.Y.-T., Prado R., Sanchez-Ramos J., Zhao W., Dietrich W.D., Busto R., Ginsberg M.D. A dual role for nitric oxide in NMDA-mediated toxicity in vivo. J. Cereb. Blood Flow Metab. 15:1995;904-913.
28. Gopalakrishna R., Chen Z.H., Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268:1993;27180-27185.
29. Iadecola C., Pelligrino D.A., Moskowitz M.A., Lassen N.A. Nitric oxide synthase inhibition and cerebrovascular inhibition. J. Cereb. Blood Flow Metab. 14:1994;175-192.
30. Inagaki S., Suzuki K., Taniguchi N., Takagi H. Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum. Brain Res. 549:1991;174-177.
31. Izumi Y., Benz A.M., Clifford D.B., Zorumski C.F. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci. Lett. 135:1992;227-230.
32. Kalisch B.E., Connop B.P., Jhamandas K., Beninger R.J., Boegman R.J. Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci. Lett. 219:1996;1-4.
33. Kalisch B.E., Boegman R.J., Jhamandas K., Beninger R.J. Modulation of quinolinic acid-induced neuronal damage to striatal NADPH diaphorase neurons by inhibition of nitric oxide synthase (NOS). Soc. Neurosci. 21:1995;75. Abstr.
34. G-hydroxy-L-arginine as an intermediate. J. Biol. Chem. 268:1993;14781-14787.
35. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B. Jr., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
36. Lees G.J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-322.
37. Lipton S.A., Choi Y., Pan Z., Lei S.Z., Chen H.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-631.
38. MacKenzie G.M., Jenner P., Marsden C.D. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience. 67:1995;357-371.
39. MacKenzie G.M., Jenner P., Marsden C.D. Effects of 7-nitro indazole on quinolinic acid-induced striatal toxicity in the rat. NeuroReport. 6:1995;1784-1789.
40. MacKenzie G.M., Rose S., Bland-Ward P.A., Moore P.K., Jenner P., Marsden C.D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport. 5:1994;1993-1996.
41. Manzoni O., Bockaert J. Nitric oxide synthase activity endogenously modulates NMDA receptors. J. Neurochem. 61:1993;368-370.
42. Martin J.B. Huntington's disease: new approaches to an old problem. Neurology. 34:1984;1059-1072.
43. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem. Biophys. Res. Commun. 164:1989;678-685.
44. Medina L., Figueredo-Cardenas G., Reiner A. Differential abundance of superoxide dismutase in interneurons versus projection neurons and in matrix versus striosomes in monkey striatum. Brain Res. 708:1996;59-70.
45. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
46. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
47. Moore P.K., Wallace P., Gaffen Z.A., Hart S.L., C Babbedge R. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
48. Murohara T., Calia R., Lefer A.M. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ. Res. 78:1996;780-789.
49. Nowicki J.P., Duval D., Poignet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
50. Oertel W.H., Magnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47:1984;122-124.
51. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Orlando, FL (1986).
52. Perkins M.N., Stone T.W. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247:1982;184-187.
53. Price R.H. Jr., Mayer B., Beitz A.J. Nitric oxide synthase neurons in rat brain express more NMDA receptor mRNA than non-NOS neurons. NeuroReport. 4:1993;807-810.
54. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 85:1988;533-537.
55. Roberts R.C., Ahn A., Swarta K.J., Beal M.F., DiFiglia M. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp. Neurol. 121:1993;274-282.
56. Schulz J.B., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D.R., Cipolloni P.B., Mecocci P., Kowall N.W., Rosen B.R., Beal M.F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
57. Schwarcz R., Whetsell W.O. Jr., Mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-318.
58. 2+ responses to N-methyl-D-aspartate and depolarization in cerebellar granule cells. J. Neurochem. 61:1993;760-763.
59. Tingley W.G., Roche K.W., Thompson A.K., Huganir R.L. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature. 364:1993;70-73.
60. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
61. G-Nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils. Neurosci. Lett. 146:1992;139-142.
62. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9813-9817.
63. Yamamoto S., Golanov E.V., Berger S.B., Reis D.J. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J. Cereb. Blood Flow Metab. 12:1992;717-726.
64. Zhang F., Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal cerebral ischemia. NeuroReport. 4:1993;559-562.